Bliss Bio Health, an artificial intelligence-infused life sciences marketing and communications firm in Holmdel, on Wednesday announced it appointed industry veteran Lisa Davidson as executive vice president and lead for client services and global business development.
She will be located in the firm’s New York City office.
“I am thrilled that our team and clients will benefit from Lisa’s deep experience in working ‘from atom to access’ with both integrated agency teams and health care companies in a wide range of disease areas,” Gloria Vanderham, CEO of Bliss Bio Health, said. “Lisa will help us redefine the life sciences and health care marketing communications landscape.”
Davidson is a respected health care public relations leader with more than 25 years of experience working with some of the most admired and impactful companies across the changing landscape. She was previously global managing director at Havas Health & You and has worked in leadership positions at BCW, Burson-Marsteller and Porter Novelli. Davidson brings expertise in preclinical and clinical educational campaigns, advocacy development, product marketing, medical devices, reputation and issues management.
“I’m excited to join Bliss Bio Health and the extended Next Practices Group Health leadership team at a time when technology can help shift communications to better meet the needs of patients and providers alike,” Davidson said. “Like so many of us, I’ve navigated health care journeys as a patient and a caregiver, so working with this team dedicated to improving and preserving health is meaningful.”
The appointment follows the announcement in January that Vanderham will lead both Next Practices Group Health and Bliss Bio Health as CEO to help clients across the health continuum disrupt the health care ecosystem and remove barriers to optimal care with an unrelenting focus on the whole person and their health journey.
